Expansion Opportunity Recent client win at Hadassah Medical Organization and public launch of the EHR-to-EDC data integration platform indicate strong market traction in the clinical trials space, presenting a recurring sales opportunity with health systems and research institutions seeking real-time data capture and better data quality.

Financial Growth Funding of 8.9M and a revenue range of 1M to 10M suggest the company is in a growth phase with budget capacity for expansion, partnerships, and onboarding of additional biotech, pharmaceutical, and academic sponsors seeking integrated data management solutions.

SaaS Upsell EHR-to-EDC streaming and AI-driven CRF mapping denote a scalable SaaS platform that can be expanded with additional modules such as broader data types, analytics, and automations for trial management, enabling cross-sell to existing customers and new sponsors.

Strategic Partnerships Notable reference with Hadassah indicates potential for reference-based selling, collaboration opportunities with research hospitals, and channel leverage to expand into other large medical centers and CRO networks.

Operational Efficiency By reducing manual data capture and staff burnout while accelerating real-time data transfer, Yonalink positions itself as a value-focused partner for organizations prioritizing speed, accuracy, and regulatory compliance in costly clinical trials.